Why the study?
Does aorta-to-coronary artery saphenous vein bypass grafting improve symptoms and survival in patients with myocardial ischemia?
Does aorta-to-coronary artery saphenous vein bypass grafting improve symptoms and survival in patients with myocardial ischemia?
Aorta-to-coronary artery saphenous vein bypass grafting provides immediate symptom relief in patients with myocardial ischemia, with an operative mortality of 10%.
Answers are grounded in this paper and cite their sources.
Bypass grafting was associated with symptom relief; leaves open survival benefit and need for randomized confirmation.
The surgical treatment of myocardial ischemia demands immediate revascularization. In 70 patients this demand was met by the use of 114 aorta-to-coronary artery saphenous vein bypass grafts. Thirty-four single, 28 double, and 8 triple bypass grafts were used. They were taken to the right coronary artery (38 times), to the left anterior descending coronary artery (60 times), and to the circumflex coronary artery (16 times). There were 28 patients with three-vessel coronary disease (stenosis greater than 75%) and 15 with two-vessel disease. In spite of this, the operative mortality was only 10% (7 of 70), and four patients died of their disease while awaiting surgery. Relief of symptoms, which occurs without delay, has continued in 81% of the patients (57 of 70). The use of aorta-to-coronary artery saphenous vein bypass grafts "jump grafts" is proposed as being widely applicable, very effective, and the safest procedure available for the surgical treatment of coronary artery occlusive disease. More observations on longterm results are still needed.
No takes yet. Share an insight, caveat, or question.
Adam et al. (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: